Peri, Anna Maria https://orcid.org/0000-0002-7704-4728
Rossio, Raffaella
Tafuri, Francesco
Benzecry, Valentina
Grancini, Anna
Reda, Gianluigi
Bandera, Alessandra
Peyvandi, Flora
Article History
Received: 26 September 2019
Accepted: 28 October 2019
First Online: 18 November 2019
Compliance with ethical standards
:
: AB has received personal fees including consultancy and travel grants from Gilead Sciences, Janssen Pharmaceuticals, ViiV Healthcare, Merck Sharp & Dohme, Nordic Pharma, Pfizer, and AbbVie. She has also received research grants from Gilead Sciences. FP has received honoraria for participating as a speaker at satellite symposia and educational meetings organized by Bioverativ, CSL Behring, Grifols, Novo Nordisk, Roche, Sanofi, Sobi, Spark Therapeutics, Sysmex, and Takeda. She is also member of the scientific advisory board of Sanofi. Other authors have no conflicts of interest to declare.
: Not applicable since the paper does not contain any studies performed by the authors.
: Written informed consent for publication of their clinical details and clinical images was obtained from the patient.